Asia-Pacific Point-of-care Diagnostic Infectious Disease Market was worth USD 346.9 million in 2016 and estimated to reach USD 686.8 million by the end of 2021 with a CAGR of 14.64%. Point-of-care diagnostics allow a speedy, convenient, and cost-efficient way to diagnose infectious diseases at healthcare centers and hospitals. Point-of-care diagnostics is a term collectively used for diagnostic procedures and tests performed on-site. As compared to conventional in-laboratory tests, point-of-care diagnostics have the advantage of speed and convenience without compromising on consistency. Point-of-care diagnostics help cut down on the need for sophisticated diagnostic systems for regular tests like infectious disease tests.
Many advanced point of care diagnostic infectious disease tests are on the verge of being used practically and widely. But, more than innovative and advanced point-of-care devices, there is an extensive need for inexpensive solutions that can be set up in regions where infectious diseases are highly prevalent. In developing regions, these tests are crucial in counterbalancing the lack of adequate laboratory capacity. This is one of the most promising opportunities that can be grabbed by market players.
Factors such as Increasing Prevalence of Infectious Diseases, Technological Advancements, Limited Resource Usability among others are expected to serve the point-of-care diagnostic infectious disease market as a vital driver. However, there are some certain market restraints that players need to overcome. Outcome reliability, Data Storage Issues, Reluctance of End-Users are limiting the growth of point-of-care diagnostic infectious disease market.
The Asia-Pacific point-of-care diagnostic Infectious disease market is segmented based on product type, infection, Technology and End users. Product type is further segmented into Consumables, instruments, Accessories. By infection, the market is segmented into viruses, Bacteria, protozoa and others. Viruses are further segmented into HIV, Influenza A&B, Hepatitis B & C, RSV and others. Bacteria is further segmented into H.Pylori, Syphilis, Streptococcus and Other bacterial Infections. By Technology the market is segmented into Lateral Flow Technology, Flow – Through Technology, DPP technology and others. By End-Users, the market has been further segmented as clinics, hospitals, homecare, Diagnostic centers and others.
On the basis of geography, the Asia-Pacific market is analyzed under various countries namely China, japan, India, Australia and New Zealand, South Korea, ASEAN and Others. Emerging markets such as India offer high growth potential for companies involved in the development and distribution of point-of-care diagnostic devices. Increasing initiatives by market players, growing patient population base, and rise in the number of partnerships and joint ventures among point-of-care providers are the key factors driving the growth of point-of-care diagnostics market in emerging countries.
Some of the major players in this market are Abbott Laboratories, Inc., Roche Diagnostics Limited, Alere Inc., BioMerieux, EFK Diagnostics, Chembio Diagnostics Systems, Response Biomedical, Accurex Biomedical Pvt. Ltd., BlueCross BioMedical and InTec Products, Inc.
Enquire Before Buying Report @ http://www.orbisresearch.com/contacts/enquiry-before-buying/255792
Some Major Points From List Of Tables:
1 INTRODUCTION :
1.1 MARKET DEFINITION
1.2 KEY DELIVERABLES OF THE STUDY
1.3 BASE CURRENCY, BASE YEAR, AND FORECAST PERIOD
1.4 GENERAL STUDY ASSUMPTIONS
2 RESEARCH APPROACH AND METHODOLOGY
2.1 INTRODUCTION :
2.1.1 SIZE ESTIMATION
2.1.2 FORECASTING METHODOLOGY
2.2 RESEARCH PHASES
2.2.1 Secondary research
2.2.2 Primary research
2.2.3 Econometric modelling
2.2.4 Expert validation
2.3 ANALYSIS DESIGN
2.4 STUDY TIMELINE.
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Email ID: firstname.lastname@example.org